bisbenzimidazole has been researched along with Cancer of Nasopharynx in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SM | 1 |
| Liu, JP | 1 |
| Zhou, JX | 1 |
| Chen, C | 1 |
| Deng, YQ | 1 |
| Wang, Y | 1 |
| Tao, ZZ | 1 |
1 other study available for bisbenzimidazole and Cancer of Nasopharynx
| Article | Year |
|---|---|
Suppression of the notch signaling pathway by γ-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferation.
Topics: Amyloid Precursor Protein Secretases; Apoptosis; Bisbenzimidazole; Carcinoma; Cell Cycle; Cell Line, | 2011 |